✦ LIBER ✦

Targeted treatment and new agents in peripheral T-cell lymphoma

✍ Scribed by Jasmine M. Zain; Owen O’Connor

Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 404 KB
Volume: 92
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0614-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted treatment and new agents in dif

Targeted treatment and new agents in diffuse large B cell lymphoma

✍ Sophie Dupire; Bertrand Coiffier 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 244 KB

Targeted treatment and new agents in fol

Targeted treatment and new agents in follicular lymphoma

✍ Bruce D. Cheson 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 174 KB

Current treatment strategy and new agent

Current treatment strategy and new agents in mantle cell lymphoma

✍ Michinori Ogura 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 250 KB

Recent developments in the treatment of

Recent developments in the treatment of peripheral T-cell lymphoma

✍ G. Hopfinger; N. Weit; M. Herling 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 135 KB

Progress in treatment of peripheral T-ce

Progress in treatment of peripheral T-cell lymphoma with hematopoietic stem cell transplantation

✍ Lilan Zhou; Mingsheng He 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

Inhibition of mammalian target of rapamy

Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas

✍ Nadine Darwiche; Ansam Sinjab; Ghada Abou-Lteif; Mirella Bou Chedid; Olivier Her 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 731 KB

## Abstract HTLV‐I‐associated adult T‐cell leukemia/lymphoma (ATL) and human T‐cell lymphotropic virus type I (HTLV‐I)‐negative peripheral T‐cell lymphomas carry poor prognosis mainly because of acquired resistance to chemotherapy. We have shown that this disease is responsive to the combination of